Homo sapiens systemic RNA interference-defective-1 transmembrane family member 1 (SIDT1) protein mediates contact-dependent small RNA transfer and microRNA-21-driven chemoresistance

Journal of Biological Chemistry

Volumn 287, Issue 8, 2012, Pages 5267-5277

  Elhassan, Mohamed O ^a,b   Christie, Jennifer ^b   Duxbury, Mark S ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAENORHABDITIS ELEGANS; CHEMORESISTANCE; CYTOTOXIC AGENTS; DRUG RESISTANCE; GEMCITABINE; HOMO SAPIENS; HUMAN ADENOCARCINOMA; HUMAN CANCER CELLS; HUMAN CELLS; POST-TRANSCRIPTIONAL GENE SILENCING; RNA INTERFERENCE; SMALL RNA; SPATIAL PROPAGATION; TRANSFER MECHANISMS; TRANSMEMBRANES;

AUTONOMOUS AGENTS; CELLS; CYTOLOGY; GENETIC ENGINEERING;

RNA;

GEMCITABINE; MEMBRANE PROTEIN; MICRORNA 21; RNA; SMALL RNA; SYSTEMIC RNA INTERFERENCE DEFECTIVE 1 TRANSMEMBRANE FAMILY MEMBER 1 PROTEIN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; CANCER RESISTANCE; CELL CONTACT; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RNA INTERFERENCE; RNA TRANSPORT; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; BASE SEQUENCE; CELL ADHESION; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HEK293 CELLS; HUMANS; INTRACELLULAR SPACE; MEMBRANE TRANSPORT PROTEINS; MICRORNAS; RNA, SMALL INTERFERING; TIME FACTORS;

EID: 84857264871     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.318865     Document Type: Article

References (62)

1. Chitwood, D. H., and Timmermans, M. C. (2010) Small RNAs are on the move. Nature 467, 415-419
2. Herr, A. J., and Baulcombe, D. C. (2004)RNAsilencing pathways in plants. Cold Spring Harb. Symp. Quant. Biol. 69, 363-370
3. Baulcombe, D. (2004) RNA silencing in plants. Nature 431, 356-363
4. Jose, A. M., and Hunter, C. P. (2007) Transport of sequence-specific RNA interference information between cells. Annu. Rev. Genet. 41, 305-330
5. Winston, W. M., Molodowitch, C., and Hunter, C. P. (2002) Systemic RNAi in C. elegans requires the putative transmembrane protein SID-1. Science 295, 2456-2459 (Pubitemid 34270260)
6. Feinberg, E. H., and Hunter, C. P. (2003) Transport of dsRNA into cells by the transmembrane protein SID-1. Science 301, 1545-1547 (Pubitemid 37128548)
7. Li, H., Coghlan, A., Ruan, J., Coin, L. J., Hériché, J. K., Osmotherly, L., Li, R., Liu, T., Zhang, Z., Bolund, L., Wong, G. K., Zheng, W., Dehal, P., Wang, J., and Durbin, R. (2006) TreeFam. A curated database of phylogenetic trees of animal gene families. Nucleic Acids Res. 34, D572-580
8. Tomoyasu, Y., Miller, S. C., Tomita, S., Schoppmeier, M., Grossmann, D., and Bucher, G. (2008) Exploring systemic RNA interference in insects. A genome-wide survey for RNAi genes in Tribolium. Genome Biol. 9, R10
9. Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., Cooke, M. P., Walker, J. R., and Hogenesch, J. B. (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. U.S.A. 101, 6062-6067 (Pubitemid 38520528)
10. Hunter, C. P., Winston, W. M., Molodowitch, C., Feinberg, E. H., Shih, J., Sutherlin, M., Wright, A. J., and Fitzgerald, M. C. (2006) Systemic RNAi in Caenorhabditis elegans. Cold Spring Harb. Symp. Quant. Biol. 71, 95-100
11. Shih, J. D., and Hunter, C. P. (2011) SID-1 is a dsRNA-selective dsRNA-gated channel. RNA 17, 1057-1065
12. Duxbury, M. S., Ashley, S. W., and Whang, E. E. (2005) RNA interference. A mammalian SID-1 homologue enhances siRNA uptake and gene silencing efficacy in human cells. Biochem. Biophys. Res. Commun. 331, 459-463 (Pubitemid 40602659)
13. Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., Zimmermann, T., Koteliansky, V., Manoharan, M., and Stoffel, M. (2007) Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat. Biotechnol. 25, 1149-1157 (Pubitemid 47538115)
14. Tsang, S. Y., Moore, J. C., Huizen, R. V., Chan, C. W., and Li, R. A. (2007) Ectopic expression of systemic RNA interference-defective protein in embryonic stem cells. Biochem. Biophys. Res. Commun. 357, 480-486 (Pubitemid 46603156)
15. Dinger, M. E., Mercer, T. R., and Mattick, J. S. (2008) RNAs as extracellular signaling molecules. J. Mol. Endocrinol. 40, 151-159 (Pubitemid 351586824)
16. Macfarlane, L. A., and Murphy, P. R. (2010) MicroRNA. Biogenesis, Function, and Role in Cancer. Curr. Genomics 11, 537-561
17. Inui, M., Martello, G., and Piccolo, S. (2010) MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 11, 252-263
18. Patek, P. Q., Lin, Y., and Case, P. G. (1989) Cell lines cultured at high density are resistant to lysis by tumor necrosis factor and natural cytotoxic cells. Proc. Soc. Exp. Biol. Med. 190, 234-239 (Pubitemid 19082216)
19. Kobayashi, H., Man, S., Graham, C. H., Kapitain, S. J., Teicher, B. A., and Kerbel, R. S. (1993) Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc. Natl. Acad. Sci. U.S.A. 90, 3294-3298 (Pubitemid 23111352)
20. Green, S. K., Frankel, A., and Kerbel, R. S. (1999) Adhesion-dependent multicellular drug resistance. Anticancer Drug Des. 14, 153-168 (Pubitemid 29292312)
21. Lwin, T., Lin, J., Choi, Y. S., Zhang, X., Moscinski, L. C., Wright, K. L., Sotomayor, E. M., Dalton, W. S., and Tao, J. (2010) Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a. Blood 116, 5228-5236
22. Krichevsky, A. M., and Gabriely, G. (2009) miR-21. A small multifaceted RNA. J. Cell Mol. Med. 13, 39-53
23. Bai, H., Xu, R., Cao, Z., Wei, D., and Wang, C. (2011) Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line. FEBS Lett. 585, 402-408
24. Misawa, A., Katayama, R., Koike, S., Tomida, A., Watanabe, T., and Fujita, N. (2010) AP-1-dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP cells. Oncol. Res. 19, 23-33
25. Pan, X., Wang, Z. X., and Wang, R. (2011) MicroRNA-21. A novel therapeutic target in human cancer. Cancer Biol. Ther. 10, 1224-1232
26. Giovannetti, E., Funel, N., Peters, G. J., Del Chiaro, M., Erozenci, L. A., Vasile, E., Leon, L. G., Pollina, L. E., Groen, A., Falcone, A., Danesi, R., Campani, D., Verheul, H. M., and Boggi, U. (2010) MicroRNA-21 in pancreatic cancer. Correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res. 70, 4528-4538
27. Fujita, H., Ohuchida, K., Mizumoto, K., Egami, T., Miyoshi, K., Moriyama, T., Cui, L., Yu, J., Zhao, M., Manabe, T., and Tanaka, M. (2009) Tumor-stromal interactions with direct cell contacts enhance proliferation of human pancreatic carcinoma cells. Cancer Sci. 100, 2309-2317
28. Duxbury, M. S., Ito, H., Ashley, S. W., and Whang, E. E. (2004) CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells. J. Biol. Chem. 279, 23176-23182 (Pubitemid 38685623)
29. Bachem, M. G., Schünemann, M., Ramadani, M., Siech, M., Beger, H., Buck, A., Zhou, S., Schmid-Kotsas, A., and Adler, G. (2005) Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 128, 907-921 (Pubitemid 40523543)
30. Kiang, D. T., Kollander, R., Lin, H. H., LaVilla, S., and Atkinson, M. M. (1994) Measurement of gap junction conduction by fluorescence activated cell sorting. In Vitro Cell. Dev. Biol. Anim. 30A, 796-802 (Pubitemid 24376745)
31. Duxbury, M. S., and Whang, E. E. (2007) RRM2 induces NF-κB- dependent MMP-9 activation and enhances cellular invasiveness. Biochem. Biophys. Res. Commun. 354, 190-196 (Pubitemid 46123218)
32. Raitano, A. B., Scuderi, P., and Korc, M. (1990) Binding and biological effects of tumor necrosis factor and γ interferon in human pancreatic carcinoma cells. Pancreas 5, 267-277 (Pubitemid 20149060)
33. Duxbury, M. S., Ito, H., Benoit, E., Waseem, T., Ashley, S. W., and Whang, E. E. (2004) A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. Cancer Res. 64, 3987-3993 (Pubitemid 38697314)
34. Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., Wong, K. K., Brandstetter, K., Wittner, B., Ramaswamy, S., Classon, M., and Settleman, J. (2010) A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141, 69-80
35. Bantly, A. D., Gray, B. D., Breslin, E., Weinstein, E. G., Muirhead, K. A., Ohlsson-Wilhelm, B. M., and Moore, J. S. (2007) CellVue Claret, a new far-red dye, facilitates polychromatic assessment of immune cell proliferation. Immunol. Invest. 36, 581-605
36. Horan, P. K., and Slezak, S. E. (1989) Stable cell membrane labeling. Nature 340, 167-168
37. Wallace, P. K., Palmer, L. D., Perry-Lalley, D., Bolton, E. S., Alexander, R. B., Horan, P. K., Yang, J. C., and Muirhead, K. A. (1993) Mechanisms of adoptive immunotherapy. Improved methods for in vivo tracking of tumor-infiltrating lymphocytes and lymphokine-activated killer cells. Cancer Res. 53, 2358-2367 (Pubitemid 23156825)
38. Rechavi, O., Erlich, Y., Amram, H., Flomenblit, L., Karginov, F. V., Goldstein, I., Hannon, G. J., and Kloog, Y. (2009) Cell contact-dependent acquisition of cellular and viral nonautonomously encoded small RNAs. Genes Dev. 23, 1971-1979
39. Rocha, J. J., Korolchuk, V. I., Robinson, I. M., and O'Kane, C. J. (2011) A phagocytic route for uptake of double-stranded RNA in RNAi. PLoS One 6, e19087
40. Toyofuku, T., Yabuki, M., Otsu, K., Kuzuya, T., Hori, M., and Tada, M. (1998) Intercellular calcium signaling via gap junction in connexin-43- transfected cells. J. Biol. Chem. 273, 1519-1528 (Pubitemid 28133675)
41. John, S. A., Kondo, R., Wang, S. Y., Goldhaber, J. I., and Weiss, J. N. (1999) Connexin-43 hemichannels opened by metabolic inhibition. J. Biol. Chem. 274, 236-240 (Pubitemid 29035054)
42. McSpadden, L. C., Kirkton, R. D., and Bursac, N. (2009) Electrotonic loading of anisotropic cardiac monolayers by unexcitable cells depends on connexin type and expression level. Am. J. Physiol. Cell Physiol. 297, C339-351
43. Wolvetang, E. J., Pera, M. F., and Zuckerman, K. S. (2007) Gap junction-mediated transport of shRNA between human embryonic stem cells. Biochem. Biophys. Res. Commun. 363, 610-615 (Pubitemid 47520681)
44. Valiunas, V., Polosina, Y. Y., Miller, H., Potapova, I. A., Valiuniene, L., Doronin, S., Mathias, R. T., Robinson, R. B., Rosen, M. R., Cohen, I. S., and Brink, P. R. (2005) Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions. J. Physiol. 568, 459-468 (Pubitemid 41555451)
45. el-Fouly, M. H., Trosko, J. E., and Chang, C. C. (1987) Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication. Exp. Cell Res. 168, 422-430 (Pubitemid 17012631)
46. Goldberg, G. S., Moreno, A. P., Bechberger, J. F., Hearn, S. S., Shivers, R. R., MacPhee, D. J., Zhang, Y. C., and Naus, C. C. (1996) Evidence that disruption of connexon particle arrangements in gap junction plaques is associated with inhibition of gap junctional communication by a glycyrrhetinic acid derivative. Exp. Cell Res. 222, 48-53 (Pubitemid 26043711)
47. Lahlou, H., Fanjul, M., Pradayrol, L., Susini, C., and Pyronnet, S. (2005) Restoration of functional gap junctions through internal ribosome entry site-dependent synthesis of endogenous connexins in density-inhibited cancer cells. Mol. Cell. Biol. 25, 4034-4045 (Pubitemid 40617652)
48. Abbruzzese, J. L., Grunewald, R., Weeks, E. A., Gravel, D., Adams, T., Nowak, B., Mineishi, S., Tarassoff, P., Satterlee, W., and Raber, M. N. (1991) A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J. Clin. Oncol. 9, 491-498
49. Bhargava, P., Marshall, J. L., Fried, K., Williams, M., Lefebvre, P., Dahut, W., Hanfelt, J., Gehan, E., Figuera, M., Hawkins, M. J., and Rizvi, N. A. (2001) Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer. Cancer Chemother. Pharmacol. 48, 95-103 (Pubitemid 32710219)
50. van Riel, J. M., Peters, G. J., Mammatas, L. H., Honeywell, R. J., Laan, A. C., Ruyter, R., van den Berg, F. G., Giaccone, G., and van Groeningen, C. J. (2009) A phase I and pharmacokinetic study of gemcitabine given by 24-h hepatic arterial infusion. Eur. J. Cancer 45, 2519-2527
51. Grunewald, R., Abbruzzese, J. L., Tarassoff, P., and Plunkett, W. (1991) Saturation of 2′,2′-difluorodeoxycytidine 5′-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine. Cancer Chemother. Pharmacol. 27, 258-262
52. Veltkamp, S. A., Beijnen, J. H., and Schellens, J. H. (2008) Prolonged versus standard gemcitabine infusion. Translation of molecular pharmacology to new treatment strategy. Oncologist 13, 261-276 (Pubitemid 351679901)
53. Dalton, W. S. (1999) The tumor microenvironment as a determinant of drug response and resistance. Drug Resist. Updat. 2, 285-288
54. Bachem, M. G., Schneider, E., Gross, H., Weidenbach, H., Schmid, R. M., Menke, A., Siech, M., Beger, H., Grünert, A., and Adler, G. (1998) Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 115, 421-432
55. Hwang, H. W., Wentzel, E. A., and Mendell, J. T. (2009) Cell-cell contact globally activates microRNA biogenesis. Proc. Natl. Acad. Sci. U.S.A. 106, 7016-7021
56. Garcia-Rodríguez, L., Pérez-Torras, S., Carrió, M., Cascante, A., García-Ribas, I., Mazo, A., and Fillat, C. (2011) Connexin-26 is a key factor mediating gemcitabine bystander effect. Mol. Cancer Ther. 10, 505-517
57. Cottin, S., Ghani, K., de Campos-Lima, P. O., and Caruso, M. (2010) Gemcitabine intercellular diffusion mediated by gap junctions. New implications for cancer therapy. Mol. Cancer 9, 141
58. Ammerpohl, O., Trauzold, A., Schniewind, B., Griep, U., Pilarsky, C., Grutzmann, R., Saeger, H. D., Janssen, O., Sipos, B., Kloppel, G., and Kalthoff, H. (2007) Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells. Br. J. Cancer 96, 73-81 (Pubitemid 46094642)
59. Zhang, Z. Q., Zhang, W., Wang, N. Q., Bani-Yaghoub, M., Lin, Z. X., and Naus, C. C. (1998) Suppression of tumorigenicity of human lung carcinoma cells after transfection with connexin43. Carcinogenesis 19, 1889-1894 (Pubitemid 28521926)
60. Katakowski, M., Buller, B., Wang, X., Rogers, T., and Chopp, M. (2010) Functional microRNA is transferred between glioma cells. Cancer Res. 70, 8259-8263
61. Zhao, T. Y., Zou, S. P., Alimova, Y. V., Wang, G., Hauser, K. F., Ghandour, M. S., and Knapp, P. E. (2006) Short interfering RNA-induced gene silencing is transmitted between cells from the mammalian central nervous system. J. Neurochem. 98, 1541-1550 (Pubitemid 44200444)
62. Lin, J., Lwin, T., Zhao, J. J., Tam, W., Choi, Y. S., Moscinski, L. C., Dalton, W. S., Sotomayor, E. M., Wright, K. L., and Tao, J. (2011) Follicular dendritic cell-induced microRNA-mediated up-regulation of PRDM1 and down-regulation of BCL-6 in non-Hodgkin's B-cell lymphomas. Leukemia 25, 145-152